Podcast
MSL Talk: Tom Caravela, Greg Auclair
Role of the MSL in launch preparedness for new products and indications
Summary
Matt Goodwin joins Tom Caravela to discuss the crucial role of MSLs in drug launch preparation and leadership. Matt shares his career journey and insights from his experiences at MAPS. They delve into the training, expectations, and success factors for MSLs during launches, addressing common stressors and establishing key milestones. The conversation highlights common pitfalls and offers advice for MSLs navigating launch phases. They examine the skills and motivation needed for evaluating MSL candidates and discuss future trends in pharma and MSL roles. The episode concludes with a call for listener feedback and subscription.
Matt Goodwin, Vice President Medical Affairs at SC Pharmaceuticals discusses the role of the MSL in preparation and strategy for launch preparedness of new products/indications.
Learn more about…
👉 The importance of preparation and timeline for launch
👉 Training and resources for launch mode
👉 The role of field medical leadership
👉 Milestones and success factors to consider
👉 The stressors to be aware of and anticipate during a launch
MSL roles, drug launch preparation, medical affairs strategy, pharmaceutical trends, field medical leadership
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Greg Auclair
Podcast
MSL Talk: Tom Caravela
Motivation Means NOTHING…
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO